Predicting AF burden with a new catheter treatment
Part of Heart & circulation clinical trials.
This study tests a new catheter that uses pulsed field energy to treat atrial fibrillation (AF), a heart rhythm problem. It aims to see how well it reduces the amount of AF you have over time. If you have paroxysmal or persistent AF, this might be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with paroxysmal or persistent atrial fibrillation (AF), which means you have episodes of irregular heartbeat that either stop on their own within 7 days or last longer than 7 days but less than a year.
- You are between 18 and 80 years old.
- You have had at least one AF episode recorded on an ECG in the past year (for paroxysmal AF) or two ECGs showing continuous AF at least 7 days apart (for persistent AF).
- You have not had previous surgery or catheter ablation for AF.
- You do not have severe heart failure, severe heart valve problems, or a history of blood clotting issues.
- You are willing to follow all study procedures and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This study tests a new catheter to treat persistent atrial fibrillation (a type of irregular heartbeat lasting more than 7 days but less than a year). It aims to isolate the pulmonary veins and superior vena cava to restore normal rhythm. Some participants may also receive a left atrial appendage occlusion device if needed.
This study tests two types of pulsed field ablation catheters to treat persistent atrial fibrillation, a heart rhythm problem lasting more than 7 days but less than a year. The goal is to see if these catheters can safely and effectively restore a normal heart rhythm.
This trial studies a new catheter called Varipulse to treat paroxysmal atrial fibrillation (irregular heartbeats that come and go) in people whose symptoms are not controlled by medication or who can't tolerate the side effects. The procedure is done under optimized sedation to help you relax.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new catheter and generator system to treat persistent atrial fibrillation (an irregular heartbeat that lasts more than a week). It may help people whose symptoms haven't been controlled by medication and who need a procedure called ablation to fix the heart's electrical signals.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.